Quick Facts: Retatrutide at a Glance Definition: Retatrutide (LY3437943) is an investigational peptide that activates three metabolic receptors GLP-1, GIP, and glucagon through one molecule
Available at: Accessed April 19, 2019
Ill be sharing more in future articles and upcoming books, but for this article, lets talk briefly about the carnitine and metabolic connections seen in other conditions
Future Outlook The market will expand rapidly with rising global cases of diabetes and obesity
To overcome the barriers and to improve the adherence, oral GLP-1 RAs were needed, but oral protein-based drug absorption is limited because of degradation in the stomach due to low pH, proteolytic enzyme activity, and limited permeability across the gastrointestinal (GI) epithelium
However, newer GLP-1 medications, such as tirzepatide, which target both GLP-1 and GIP receptors, may be even more effective for weight loss